China Money Network
Login
Join

Zero2IPO Leads $14M Series B Round In Chinese Biotech Firm Sophonix

  • June 23, 2020 — 16:06 CST

This Data Is Locked!

This area is available only to Subscribers.

Chinese biotechnology company Sophonix has recently completed a RMB100 million (US$14.14 million) series B funding round led by Zero2IPO Asset Management. Delian Capital, Anlong Fund,... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: